IATDMCT Congress 2025 – Singapore, Sep 21 – 24

It is with warm hearts and open arms that we welcome you to the 23rd Congress of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT 2025) to be held from Sunday 21 September to Wednesday 24 September 2025 in Singapore. The congress venue, the Grand Copthorne Waterfront Hotel, is ideally located in the heart of Singapore, within walking distance of a range of fantastic restaurants, tourist attractions and hotels.

Introducing our first plenary speaker: Dr Kevin Plaxco

We are thrilled to announce that Dr. Kevin Plaxco will be joining us at IATDMCT 2025!

Kevin Plaxco, a Distinguished Professor at the University of California, Santa Barbara, holds appointments in the Departments of Chemistry and Biochemistry and of BioEngineering. Prior to joining UCSB in 1998 Dr. Plaxco received his Ph.D. from Caltech and performed postdoctoral studies at Oxford and the University of Washington. Dr. Plaxco’s research focus is on the physics of biomolecular folding and its engineering applications. A major aim of the group’s applied research is to harness the speed and specificity of folding in the development of sensors, adaptable surfaces, and smart materials. Dr. Plaxco has co-authored more than 250 papers and two dozen patents on protein folding, protein dynamics, and folding-based sensors and materials. He serves on the scientific boards of many biotechnology firms, several of which are commercializing technologies developed by his group. Dr. Plaxco has also written a popular science book on Astrobiology.

Don't miss Dr Plaxco's must-see presentation!

Only one week left to submit your abstract

The deadline to submit your abstract for the IATDMCT 2025 Congress is fast approaching! You have just one week left to share your research and contribute to this exciting event.

Don't miss your chance to be part of this global gathering of experts. Submit your abstract today!

More information about the submission guidelines is available on the congress website.

IMPORTANT DATES

2025

• 28 February: Abstract submission deadline – Submit Now!
• 14 April: Abstract notification
• 20 June: Early registration deadline
• 18 July: Accommodation booking deadline
• 21 September: Congress commences

Congress Co-Chairs:
Sophie Stocker and Jana Stojanova

Congress website: iatdmct2025.org/

Contact Us: iatdmct2025@expertevents.com.au

See you in Singapore in September!

TRAVEL GRANTS

A limited number of International Travel Grants are available to help offset travel expenses to attend the IATDMCT Congress. Click here for full details and to submit an application.

Please ensure to submit all required documents as outlined on the application form – incomplete applications will not be eligible.

Join us in maintaining the IATDMCT membership at a high level!

Please ensure you renew your membership in order to retain your IATDMCT member benefits. Members who renew their membership for two years will receive a 10% discount on membership fees!

›› Click here to renew today

IATDMCT members are invited to nominate individuals for the IATDMCT Council.

Current members of Council are eligible for election to another office or for one reelection to a second term in their current position.

Only 2 terms may be served by any individual in any one post.

Council positions:

• President-elect
• Treasurer
• Secretary
• Director of Education (3 positions)
• Councillor (4 positions)

Nominations should be submitted using the online nomination form.

Nominations from members must be accompanied by curriculum vitae and a letter of support from the nominator. Additional letters of support from IATDMCT members are welcome.

The Call for Nominations for the 2025 IATDMCT award is open!

This year you are invited to nominate individuals for the following IATDMCT Award:

• Irving Sunshine Award, presented for outstanding contributions to Clinical Toxicology

The Call for Nominations is open until April 30, 2025. The award presentation will take place at the Opening Ceremony of the 23rd IATDMCT Congress in Singapore.

Nominations from members must be accompanied by curriculum vitae including a list of publications and a letter of support from the nominator containing an evaluation and appraisal of the nominee for the award. Additional letters of support from members of the Association or other respected scientists are welcomed as supporting information for the Selection Committee.

Submit your nominations using the online nomination form.

Join us in maintaining the IATDMCT membership! We look forward to inspiring many further colleagues who share with us the idea of an optimized and personalized drug treatment to join us in IATDMCT. Please ensure you renew your membership in order to retain your IATDMCT member benefits.

Our 2025 Member-Get-A Member Campaign is now up and running! Members are invited to inform their colleagues (who are not members yet) about the benefits of membership. Let's build a strong partnership together!

Campaign Deadline: August 31, 2025

The top recruiter (with at least 50%-paying members) will gain a free registration for the IATDMCT Congress 2025 in Singapore.

Deadline: July 31, 2025

At the 2025 IATDMCT Congress in Singapore, the venue for the 2029 Congress will be chosen.

Members interested in submitting a proposal to host the Congress must submit an application by July 31, 2025. The purpose of this application is to provide guidance for candidates and to facilitate the task of selecting the final site, for the Site Selection Committee. You may choose to submit the information required on the application form in a different format, but all questions on the form should be addressed. Very often a tourism office, conference centre, or hotel in the region can help you gather the information.

For more information on the application process, please contact: Congress Site Selection Committee

Click here to email your questions

IATDMCT has created a Regional Section for members in Europe. The aim of Regional Sections is to create more opportunities to advance TDM and CT activities within the region, with a special emphasis on young professionals to advance their knowledge and skills and encourage them to become the role models of the future.

Regional Sections have a similar structure to the Scientific Committees but are focused on regional meetings and providing education and research opportunities.

We are looking for 10-15 enthusiastic individuals from various countries, representing the breadth of the field of TDM and CT to form the Section Committee. If you would be interested in taking a leadership role in setting up and further developing European activities within IATDMCT please let us know via this poll.

IATDMCT Europe Regional Section Co-Chairs:
Anders Åsberg, Norway
Annick de Vries, Netherlands

Link to poll: https://www.surveymonkey.com/r/XP66LSG

Find the latest news and follow our IATDMCT institutional page on LinkedIn, X(Twitter) @IATDMCT or Instagram!

Dear Colleagues,

We would like to inform you about the development of a Special Issue of Therapeutic Drug Monitoring with a focus on toxicology that we plan for this year. This will be in collaboration with the Scientific Committees on Clinical Toxicology/Drugs of Misuse and on Toxicology and Environmental Health.

You are invited to consider participating in this project and to submit innovative work from your research group to the journal. Both review and original articles are welcome. The deadline for submissions is 30 June 2025. If you are interested, please contact the Reviews Editor Dr Maria Shipkova at maria.shipkova@arcor.de to share your proposals.

Furthermore, we would like to take this opportunity to remind you that our “TDM in Oncology” Special Series is an ongoing project and submissions are greatly appreciated!

Stay ahead with the latest scientific research developments in the fields of TDM and CT!

The monthly Therapeutic Drug Monitoring column provides you with the latest posts of ahead-of-print. Bringing to you articles posted online January 17 – February 5, 2025:

ORIGINAL ARTICLES:

• Eltrombopag-Induced Falsely Elevated Bilirubin Concentrations in Enzymatic and Vanadate Oxidation Assays: Involvement of High Serum Eltrombopag Concentrations
  Oda, Shun; Doki, Kosuke; Obara, Naoshi; Suzuki, Yoshiharu; Chiba, Shigeru; Homma, Masato
  February 5, 2025
• Population Pharmacokinetics of Perampanel in Chinese Pediatric and Adult Patients With Epilepsy
  Yang, Jiayu; Zhang, Sitian; Zhao, Zhigang; Mei, Shenghui; Feng, Weixing
  February 4, 2025
• Real-world Plasma Exposure of Nirmatrelvir/Ritonavir in Chinese Hospitalized Patients With COVID-19: A Multicenter Retrospective Study
  Ma, Zhiyuan; Bai, Mengru; Shen, Shuying; Zhou, Junshan; Dong, Rong; Zhang, Jiangjun; Weng, Yayun; Li, Li; Li, Yongchen; Liu, Dan; Yan, Wei; Lin, Nengming; Xia, Jianmei
  January 30, 2025
• An Approach for Improving the Detection and Quantitation of Buprenorphine and Its Metabolites in Maternal and Neonatal Hair
  Alshogran, Osama Y.; Zhao, Wenchen; Krans, Elizabeth E.; Caritis, Steve; Shaik, Imam H.; Venkataramanan, Raman
  January 23, 2025
• Multiple Model Optimal Sampling Promotes Accurate Vancomycin Area-Under-the-Curve Estimation Using a Single Sample in Critically Ill Children
  Downes, Kevin J.; Sharova, Anna; Malone, Judith; Odom John, Audrey R.; Zuppa, Athena F.; Neely, Michael N.
  January 23, 2025
• Personalized Dosing of Linezolid to Reduce the Risk of Thrombocytopenia: A Systematic Review and Meta-Analysis
  Oda, Kazutaka; Tsuruta, Takeru; Hanai, Yuki; Yamada, Tomoyuki; Komatsu, Toshiaki; Kondo, Shoji; Jono, Hirofumi; Saito, Hideyuki
  January 23, 2025

SHORT COMMUNICATION:

• Comparative Analysis of 2 Commercially Available Assays for Therapeutic Drug Monitoring of Infliximab and Adalimumab
  López Pérez, Juan; Inda-Landaluce, Mercedes; Nocito-Colón, Mercedes; Martínez-Lostao, Luis
  January 24, 2025

CASE REPORT:

• Delayed Drug–Drug Interaction Between Antiviral Drugs and Tacrolimus in a Pancreatic Islet Transplant Recipient with SARS-CoV-2 Pneumonia—A Case Study
  Sabo, Amelia-Naomi; Cunat, Sibylle; Kemmel, Véronique
  February 3, 2025

››Submit your high quality research – Information for authors.

Are you aware of additional events of potential interest for the IATDMCT society? Share this information with your IATDMCT colleagues by posting it on our Events Calendar.

» Click here to Post an Event on our Online Events Calendar today!

Visit the IATDMCT Events Calendar and stay informed about the upcoming TDM and CT Meetings. By doing this you can comfortably and directly reach all related online resources.

Topic: Clinical Case Solving with TDM

PROGRAM INCLUDES:

• Unlocking the Potential: The Essential Role of Therapeutic Drug Monitoring in Immunosuppressant Treatment
  Lim Rou Wei, Senior Principal Clinical Pharmacist, Singapore General Hospital
• Non-renal augmented clearance of linezolid
  Jana Stojanova, St. Vincent’s Hospital, Sydney, Australia
• Role of clinical pharmacologist in interpreting drug concentrations for immunosuppressant TDM
  Roopali Somani, Nizam’s Institute of Medical Sciences, Hyderabad, India
• TDM to manage tacrolimus drug interactions in renal transplantation patients
  Hoa Vu Dinh, Hanoi University of Pharmacy, Vietnam

Click here for more details and to register now!

Visit the website and learn more

Register Now!

Co-editor: Manuela Neuman
Co-editor: Ryuji Kato
Co-editor: Miao Yan

NOTE: Items appearing in the IATDMCT monthly E-News do not necessarily have the endorsement of the Association.